Initial antigen encounter determines robust T-cell immunity against SARS-CoV-2 BA.2.86 variant three years later - 13/02/25
, Gemma Moncunill a, b, l, ⁎
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Summary |
Objectives |
We aimed to evaluate the adaptive immune responses cross-recognition of the hypermutated SARS-CoV-2 BA.2.86 variant and identify the determinants influencing this recognition.
Methods |
We measured BA.2.86 neutralizing antibodies and T-cell responses cross-reactivity in previously exposed participants. We investigated clinical-demographic factors and used a novel in silico analysis to assess viral genetic determinants affecting T-cell responses.
Results |
Despite notable escape from neutralizing antibodies, T-cell responses remained generally preserved, albeit with a significant but small loss in T-cell cross-recognition (7.5%, 14.2%, and 10.8% average loss for IFN-γ, IL-2, and IFN-γ + IL-2, respectively, p<0.05). This is consistent with the prediction of 6 out of 10 immunodominant T-cell epitopes (TCEs) altered by BA.2.86 mutations to have reduced peptide presentation. This effect is expected to be mitigated by total TCEs across the genome. Remarkably, T-cell responses and cross-recognition were 3.5 (IFN-γ), 2 (IL-2) and 2.4 (IFN-γ + IL-2) times higher when first induced by infection rather than by vaccination three years earlier, by increasing number of infections, and by ancestral/Delta than Omicron infections.
Conclusions |
Our findings underscore the critical role and factors influencing T-cell immunity against evolving SARS-CoV-2 variants, such as first antigen encounter (vaccination or infection), as it is essential for developing effective control strategies.
Le texte complet de cet article est disponible en PDF.Highlights |
• | BA.2.86 evades pre-existing neutralizing antibodies, but T-cell responses persist. |
• | T-cell cross-recognition depends on first antigen encounter (infection or vaccine). |
• | Number of infections and specific infecting variant shape T-cell cross-recognition. |
• | Five immunodominant T-cell epitopes might be altered by BA.2.86 mutations. |
• | Mutations likely stem from antigenic drift or constraints, not T-cell immune pressure. |
Keywords : COVID-19, BA.2.86 cross-recognition, Pirola, T cells, Neutralizing antibodies
Plan
Vol 90 - N° 2
Article 106402- février 2025 Retour au numéro
Article précédent
- Ureaplasma parvum serovar 6 may be a novel element in the progression of HPV infection to CIN: A cross-sectional study of 7058 women
- Yingxuan Zhang, Rongdan Chen, Zuyi Zhou, Wei Qing, Cancan Qi, Jinxia Ou, Hongwei Zhou, Muxuan Chen, CALM 2004 Study Group
- Immunogenicity, safety, and reactogenicity of concomitant administration of the novavax vaccine against Omicron XBB.1.5 (NVX-CoV2601) and a 20-valent pneumococcal conjugate vaccine in adults aged ≥60 years: A randomised, double-blind, placebo-controlled, non-inferiority trial
- Anselm Jorda, Marlene Prager, Lena Pracher, Patrick Haselwanter, Matthias Jackwerth, Valentin al Jalali, Erdem Yildiz, Amelie Leutzendorff, Maria Weber, Schermin Yourieva, Paula Kammerer, Theresa Pecho, Alice Decaminada, Lena Ederer, Ursula Wiedermann, Lukas Weseslindtner, Monika Redlberger-Fritz, Felix Bergmann, Markus Zeitlinger
Bienvenue sur EM-consulte, la référence des professionnels de santé.